WO2011052884A3 - 테오브로민 함유 서방성 정제 - Google Patents

테오브로민 함유 서방성 정제 Download PDF

Info

Publication number
WO2011052884A3
WO2011052884A3 PCT/KR2010/005911 KR2010005911W WO2011052884A3 WO 2011052884 A3 WO2011052884 A3 WO 2011052884A3 KR 2010005911 W KR2010005911 W KR 2010005911W WO 2011052884 A3 WO2011052884 A3 WO 2011052884A3
Authority
WO
WIPO (PCT)
Prior art keywords
sustained release
theobromine
tablet containing
release layer
release tablet
Prior art date
Application number
PCT/KR2010/005911
Other languages
English (en)
French (fr)
Other versions
WO2011052884A2 (ko
Inventor
어진
김창환
한창균
정현근
김양중
김종걸
윤주용
이정화
Original Assignee
안국약품 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안국약품 주식회사 filed Critical 안국약품 주식회사
Priority to CN201080051266.9A priority Critical patent/CN102711740B/zh
Priority to RU2012119070/15A priority patent/RU2506947C2/ru
Priority to UAA201206606A priority patent/UA103558C2/ru
Priority to BR112012010325A priority patent/BR112012010325B8/pt
Publication of WO2011052884A2 publication Critical patent/WO2011052884A2/ko
Publication of WO2011052884A3 publication Critical patent/WO2011052884A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Abstract

본 발명은 테오브로민 함유 서방성 정제에 관한 것으로서, 좀더 상세히 설명하면, 활성성분인 테오브로민 40~60 중량%와 폴리에칠렌옥시드와 히드록시프로필 메칠셀룰로오스로 이루어진 서방성 기제 14~19 중량%를 포함하여 이루어진 서방출층과, 활성성분인 테오브로민 10~30 중량%와 크로스카멜로오스나트륨, 크로스포비돈, 전분글리콘산나트륨 중에서 선택된 어느 하나 또는 둘 이상으로 이루어진 붕해제 0.5~2 중량%를 포함하여 이루어진 속방출층으로 구성되어 있어서, 1일 1회 복용만으로도 각종 기침 증상을 효과적으로 개선할 수 있는 테오브로민 함유 서방성 정제에 관한 것이다.
PCT/KR2010/005911 2009-11-02 2010-09-01 테오브로민 함유 서방성 정제 WO2011052884A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201080051266.9A CN102711740B (zh) 2009-11-02 2010-09-01 含可可碱的缓释锭剂
RU2012119070/15A RU2506947C2 (ru) 2009-11-02 2010-09-01 Таблетка пролонгированного высвобождения, содержащая теобромин
UAA201206606A UA103558C2 (ru) 2009-11-02 2010-09-01 Таблетка пролонгированного высвобождения, которая содержит теобромин
BR112012010325A BR112012010325B8 (pt) 2009-11-02 2010-09-01 comprimido com liberação sustentada e imediata de teobromina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0105137 2009-11-02
KR1020090105137A KR101137467B1 (ko) 2009-11-02 2009-11-02 테오브로민 함유 서방성 정제

Publications (2)

Publication Number Publication Date
WO2011052884A2 WO2011052884A2 (ko) 2011-05-05
WO2011052884A3 true WO2011052884A3 (ko) 2011-07-14

Family

ID=43922740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/005911 WO2011052884A2 (ko) 2009-11-02 2010-09-01 테오브로민 함유 서방성 정제

Country Status (7)

Country Link
KR (1) KR101137467B1 (ko)
CN (1) CN102711740B (ko)
BR (1) BR112012010325B8 (ko)
RU (1) RU2506947C2 (ko)
TR (1) TR201205029T1 (ko)
UA (1) UA103558C2 (ko)
WO (1) WO2011052884A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101220830B1 (ko) * 2010-08-18 2013-01-10 안국약품 주식회사 테오브로민의 서방성 과립제 및 그 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060113728A (ko) * 2003-11-13 2006-11-02 룀 게엠베하 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태
KR20070017335A (ko) * 2004-03-22 2007-02-09 노파르티스 아게 리카르바제핀을 포함하는 경구투여용 매트릭스 제제
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
KR20070119658A (ko) * 2005-03-29 2007-12-20 에보니크 룀 게엠베하 활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196481A1 (en) * 2002-07-25 2007-08-23 Amidon Gregory E Sustained-release tablet composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060113728A (ko) * 2003-11-13 2006-11-02 룀 게엠베하 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태
KR20070017335A (ko) * 2004-03-22 2007-02-09 노파르티스 아게 리카르바제핀을 포함하는 경구투여용 매트릭스 제제
KR20070119658A (ko) * 2005-03-29 2007-12-20 에보니크 룀 게엠베하 활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법

Also Published As

Publication number Publication date
BR112012010325A2 (pt) 2016-03-29
WO2011052884A2 (ko) 2011-05-05
CN102711740A (zh) 2012-10-03
RU2012119070A (ru) 2013-12-10
BR112012010325B8 (pt) 2021-05-25
RU2506947C2 (ru) 2014-02-20
KR101137467B1 (ko) 2012-04-20
KR20110048367A (ko) 2011-05-11
UA103558C2 (ru) 2013-10-25
BR112012010325B1 (pt) 2021-01-26
TR201205029T1 (tr) 2012-09-21
CN102711740B (zh) 2014-02-12

Similar Documents

Publication Publication Date Title
WO2011002857A3 (en) 3-cyanoquinoline tablet formulations and uses thereof
WO2007097770A8 (en) Metoprolol succinate e.r. tablets and methods for their preparation
EA017091B9 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
WO2007135529A3 (en) Azabenzimidazolyl compounds as mglur2 potentiators
UA89394C2 (uk) Композиція оланзапіну або донепезилу, що розпадається при пероральному прийомі
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
TNSN08191A1 (en) Kinase inhibitors
WO2008020820A3 (en) Pharmaceutical compositions comprising aripiprazole
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2010082220A3 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
HK1115315A1 (en) Tablet containing hardly soluble active ingredient
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
RU2008135718A (ru) Композиции клопидогреля бисульфата
WO2010115125A3 (en) Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
SI1994926T1 (sl) Farmacevtske oblike valsartana
WO2007099555A3 (en) Pharmaceutical tablet compositions containing irbesartan
WO2010137040A3 (en) Novel pharmaceutical compositions of ranolazine
WO2009097973A3 (de) Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
WO2011064797A3 (en) Controlled release pharmaceutical compositions of galantamine
WO2011052884A3 (ko) 테오브로민 함유 서방성 정제
WO2007093168A3 (de) Schnell freisetzende irbesartan-haltige pharmazeutische zusammensetzung
WO2010018593A3 (en) Gastric acid resistant benzimidazole multiple unit tablet composition
WO2011132008A3 (en) Controlled release pharmaceutical composition
WO2008064829A3 (en) Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080051266.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10826969

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2012/05029

Country of ref document: TR

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: A201206606

Country of ref document: UA

WWE Wipo information: entry into national phase

Ref document number: 2012119070

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 10826969

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012010325

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012010325

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120502